Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
INMD InMode
34.435-0.035-0.10%
Trading Session
01/31 11:40 ET
High
34.980
Open
34.530
Turnover
16.07M
Low
34.150
Pre Close
34.470
Volume
464.87K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
3 Reasons Wall Street Thinks InMode Can Rocket 47% Higher in 2023
Victory Capital Management Inc. Has $18.62 Million Holdings in InMode Ltd. (NASDAQ:INMD)
Victory Capital Management Inc. raised its holdings in InMode Ltd. (NASDAQ:INMD – Get Rating) by 3.0% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 639,613
'I Think You Should Take The Money And Run': Cramer On This Stock Up 52% Over Past Month
On CNBC's "Mad Money Lightning Round," Jim Cramer said Amicus Therapeutics Inc (NASDAQ:FOLD) is an "ideal spec." When asked about QuantumScape Corporation (NYSE:QS), he said, "I think you should
Stocks Generating Improved Relative Strength: InMode
Looking for a small-cap stock with good potential? Tech company InMode may fill that order. On Monday the Relative Strength (RS) Rating for InMode stock earned an upgrade to 75, up from 61 last week.
InMode Stock: Bull Vs. Bear
Hamilton Wealth LLC Buys New Shares in InMode Ltd. (NASDAQ:INMD)
Hamilton Wealth LLC acquired a new position in shares of InMode Ltd. (NASDAQ:INMD – Get Rating) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exc
Here's Why InMode (NASDAQ:INMD) Has Caught The Eye Of Investors
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. But as Peter Lynch said in One Up On Wall S
Analysts Set InMode Ltd. (NASDAQ:INMD) PT at $46.17
InMode Ltd. (NASDAQ:INMD – Get Rating) has been given a consensus rating of "Buy" by the seven brokerages that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated
Analysts Offer Insights on Healthcare Companies: InMode (INMD), Fulcrum Therapeutics (FULC) and Amarin (AMRN)
Avalon Investment & Advisory Has $4.20 Million Position in InMode Ltd. (NASDAQ:INMD)
Avalon Investment & Advisory lowered its position in InMode Ltd. (NASDAQ:INMD – Get Rating) by 6.3% in the third quarter, according to the company in its most recent disclosure with the Securities a
Company Overview
More
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.
CEO： Mr. Moshe Mizrahy
Market： NASDAQ
Listing Date： 08/08/2019
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet